好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Classification of Natalizumab Cases with Progressive Multifocal Leukoencephalopathy
MS and Related Diseases
(-)
058
Authors/Disclosures
Tuan Dong-Si, MD No disclosure on file
Thomas W. Weber, MD (Medizinicum) No disclosure on file
Nancy D. Richert, MD, PhD (Research Imaging LLC) No disclosure on file
Grainne Quinn, MD (Elan Pharma International Ltd.) No disclosure on file
No disclosure on file
Mariska Kooijmans-Coutinho, MD, PhD (Biogen Idec. Ltd) No disclosure on file
Carmen Bozic, MD (Biogen Idec) No disclosure on file
No disclosure on file
Gary Bloomgren, MD, MBA (Biogen Idec) No disclosure on file
Sandra R. Richman, MD No disclosure on file
James McNames No disclosure on file
David B. Clifford, MD, FAAN (Washington University School of Med) Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Excision BioTherapeutics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CellEvolve. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeuitics. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity (Medpace). Dr. Clifford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Clifford has received publishing royalties from a publication relating to health care.